Abstract
No public abstract is available from the verified source records.
Bruno Millet
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Meta-analytical studies on new antidepressants
10.1093/bmb/57.1.161 · 2001
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
10.1185/030079907x159498 · 2007
Fluoxetine in tricyclic refractory major depressive disorder
10.1016/0165-0327(90)90144-w · 1990
A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder
10.1080/10401230590932326 · 2005
Venlafaxine extended release in post-traumatic stress disorder: a sertraline- and placebo-controlled study
10.1097/01.jcp.0000222514.71390.c1 · 2006
Duloxetine in the acute and long-term treatment of major depressive disorder : a placebo- and paroxetine-controlled trial
10.1016/j.euroneuro.2004.01.002 · 2004
Neuroimaging studies of mood disorders
10.1016/s0006-3223(00)01020-9 · 2002
Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy
2005
A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder
10.1016/s0924-9338(03)00046-4 · 2003
A susceptibility gene for affective disorders and the reponse of the human amygdala
10.1001/archpsyc.62.2.146 · 2005
Antidepressant treatment of depression : a meta-analysis
10.1177/070674379604101002 · 1996
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder
10.1111/j.1440-1819.2006.01512.x · 2006
SAD Study Group. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder
10.4088/jcp.v66n0213 · 2005
Potential Treatment Paradigms for Anxiety Disorders Expert Opinion on Investigational
1999
Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
10.1097/00004850-199300830-00009 · 1993
Can’t shake that feeling: event-related f MRI assessment of subtained amygdala activity in response to emotional information in depressed individuals
10.1016/s0006-3223(02)01314-8 · 2002
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder
10.4088/jcp.v62n07a04 · 2001
SNRIs : their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
10.1017/s1092852900019726 · 2005
No additional external references are available.